Practice

Nine mandates. Rarely more than a handful open at once.

Every engagement is led personally by Dr. Chow. Fees are structured as a retainer, a success participation, or an equity or board position — depending on which of those keeps the interests correctly aligned.

01
Flagship practice

UHNW & Family Office

Architecture for families whose wealth has crossed more borders than their advisers have. We work upstream of the private banks: what the structure should be, who governs it, how the next generation enters, and which relationships need to exist before the money moves.

Typical scope
Holding and trust architecture across SG/HK/UK · investment policy statement · manager selection and challenge · succession and family governance charter · consolidated reporting · discreet direct and co-investment access
Engaged by
Principals, single family offices, next-generation heirs
02
Core

M&A, Deal Negotiation & Privatisation

Sell-side and buy-side execution where the counterparty is Chinese, ASEAN or Anglo-American and the two sides are not hearing each other. Includes take-private and delisting work, where Dr. Chow has acted as principal.

Typical scope
Target sourcing and screening · valuation and structuring · lead negotiator seat at the table · due-diligence orchestration · privatisation and delisting · post-close integration governance
Engaged by
Boards, controlling shareholders, PE sponsors, founders
03
Core

Singapore Fund Structuring (VCC)

Standing up a regulated Singapore vehicle from a blank page — the route Dr. Chow executed in under three months for a multi-strategy capital VCC, including the sovereign-fund relationship that made it credible.

Typical scope
VCC and sub-fund design · MAS licensing and CMS pathway · service-provider and custodian selection · compliance and risk framework · team build-out · anchor and sovereign investor introductions
Engaged by
Fund managers entering Asia, family offices institutionalising
04
Ongoing

Board Seats, Governance & Advisory Retainers

A small number of non-executive and advisory seats each year, where the board needs someone who has actually been the CEO under regulatory and market pressure — including through the 2015 Chinese market crash.

Typical scope
Non-executive directorship · audit and risk committee · governance remediation before listing · CEO counsel and succession · crisis and shareholder-protection strategy
Engaged by
Listed and pre-listing boards, sponsors, founder-CEOs
05
Core

China & ASEAN Market Entry

For Western and Australasian groups who need the corridor to actually open. Not a market study — a sequence of introductions and a structure that survives contact with the local regulator.

Typical scope
Entry structure and licensing · partner and JV selection · institutional, securities-house and sovereign introductions · regulatory navigation · local leadership recruitment
Engaged by
UK, US, AU/NZ corporates, funds and family offices
06
Core

Growth Capital: Series B–D & Pre-IPO

Raising institutional capital at the stage where the story has to be underwritten rather than believed. Includes crossover and pre-IPO rounds positioned deliberately for a specific exchange.

Typical scope
Equity story and materials · investor mapping across Asia, UK and US · process management and competitive tension · term-sheet negotiation · cap-table and dilution strategy · investor relations after close
Engaged by
Founders and CFOs of scale-up and pre-listing companies
07
Core

IPO Readiness & Listing Advisory

Listing preparation and execution across NYSE, HKEX, SGX and SHEX — four exchanges Dr. Chow has personally operated on as chief executive or managing director.

Typical scope
Exchange selection and listing-venue economics · 12–24 month readiness programme · sponsor, underwriter and auditor selection · corporate governance rebuild · roadshow and equity narrative · post-listing IR
Engaged by
Controlling shareholders and boards, 12–36 months from listing
08
Specialist

ESG & Sustainable Investment

ESG treated as an investment discipline and a capital-access question, not a reporting chore. Built on a CFA-track ESG investing qualification and a sustainability investment platform Dr. Chow founded and runs.

Typical scope
ESG investment policy and mandate design · sustainability project origination and structuring · impact measurement against real return targets · disclosure readiness for Asian and UK investors
Engaged by
Asset owners, funds, sustainability-linked project sponsors
09
Selective

Speaking, Executive Education & Mentoring

A limited number of closed-room engagements each year. Grounded in a PhD in Accounting and Finance and two years teaching finance at postgraduate and MBA level at the University of Queensland.

Typical scope
Board and investment-committee sessions · closed family-office roundtables · executive programmes on cross-border capital · one-to-one mentoring for a small number of CEOs and founders
Engaged by
Boards, family-office networks, business schools, conferences

Enquiries are read by the principal.

We reply to every serious approach, and decline most of them. If the situation is time-critical, say so in the first line.

Request an introduction